Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma.
Bone Marrow Transplant
; 57(5): 837-839, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35260803
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Hematopoietic Stem Cell Transplantation
Limits:
Humans
Language:
En
Journal:
Bone Marrow Transplant
Journal subject:
TRANSPLANTE
Year:
2022
Document type:
Article
Affiliation country:
Italia
Country of publication:
Reino Unido